Lenvatinib Mesylate and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Lenvatinib Mesylate and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Pneumococcal 13-valent conjugate vaccine
- Lenvatinib Mesylate-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Lenvatinib Mesylate-Pneumococcal Conjugate Vaccine (13-Valent)
- Lenvatinib Mesylate-Pneumococcal Conjugate Vaccine (7-Valent)
- Lenvatinib Mesylate-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lenvatinib Mesylate-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Lenvima
- Pms-Sodium Polystyrene Sulfonate-Lenvima (14 MG Daily Dose)
- Pms-Sodium Polystyrene Sulfonate-Lenvima (18 MG Daily Dose)
- Pms-Sodium Polystyrene Sulfonate-Lenvima (20 MG Daily Dose)
- Pms-Sodium Polystyrene Sulfonate-Lenvima (24 MG Daily Dose)
- Pms-Sodium Polystyrene Sulfonate-Lenvima (8 MG Daily Dose)